Company: HVIIR
Filing Date: 2025-12-23
Form Type: S-4
Source: 0001493152-25-029121
Chunk: 393

Company: Hennessy Capital Investment Corp. VII
Filing Date: 2025-12-23
Form: S-4
Chunk 393
---
 the board of directors, any interest or expectancy of the corporation in, or being offered an opportunity to participate in, specified business opportunities or specified classes or categories of business opportunities that are presented to the corporation or one or more of its officers, directors or stockholders.

Unlike Delaware law, Cayman Islands law does not have a codified corporate opportunity doctrine and a director’s obligations in relation to business opportunities are governed by general fiduciary duties which include the duty to act in good faith and in the best interests of the company, the duty to avoid conflicts of interests and a duty to exercise independent judgement and avoid self-dealing. A Cayman Islands director may engage in business activities outside a Cayman Islands exempted company, provided that they have disclosed any personal interest in the opportunity and such action is provided for in the articles of association of the exempted company. If the director properly declares their interest at a board meeting, Cayman Islands law permits the company to approve the transaction, if the articles of association of the exempted company provide for such action. A director may also vote on resolutions related to such a contract provided the interest has been disclosed, provided the articles of association of the exempted company approve such disclosure.

| 262 |

<div align='center'>SHARES ELIGIBLE FOR FUTURE SALE</div>

As of the date of this proxy statement/prospectus, there are 26,023,333 HVII Ordinary Shares outstanding. Of these shares, the 19,000,000 HVII Class A Ordinary Shares sold in the IPO are freely tradable without restriction or further registration under the Securities Act, except for any shares purchased by one of HVII’s affiliates within the meaning of Rule 144 under the Securities Act (“Rule 144”). All of the remaining 7,023,333 HVII Ordinary Shares owned collectively by the Initial Shareholders (including the Sponsor) are restricted securities under Rule 144, in that they were issued in private transactions not involving a public offering.

As of the date of this proxy statement/prospectus, there are 19,690,000 HVII Rights outstanding, which will automatically be exchanged for up to an aggregate of 1,640,833 shares of New ONE Nuclear Common Stock at the Closing. Of these HVII Rights, the 19,000,000 HVII Public Rights sold in the IPO (and the shares of New ONE Nuclear Common to be issued at the Closing in exchange therefor) are freely tradable without restriction or further registration under the Securities Act, except